Φορτώνει......
Tocilizumab Use in COVID-19 Cytokine-release Syndrome: Retrospective Study of Two Centers
INTRODUCTION: Cytokine-release syndrome (CRS) in COVID-19 patients can cause multiorgan failure and higher mortality. We used a structured protocol based on clinical, biochemical, and interleukin 6 (IL-6) criteria for the identification of the subset of patients with CRS and analyzed the use of toci...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Indian J Crit Care Med |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Jaypee Brothers Medical Publishers
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7584850/ https://ncbi.nlm.nih.gov/pubmed/33132558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5005/jp-journals-10071-23566 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|